Evidence map›Paper›PMID 42126493›Full record

ReviewOdontology2026

The state of the art of oral lesions in HTLV-1 infection.

Linda Gabriele Gomes Cerqueira Sobral, Ariadne Yasmim Martins Alves, Juliana de Souza do Nascimento, Davi Tanajura Costa, Fernanda Khouri Barreto

Abstract readReview
PubMed Publisher
In one paragraph

Review in Odontology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Linda Gabriele Gomes Cerqueira SobralMultidisciplinary Institute in Health - Federal of Bahia University (UFBA), Vitória da Conquista, Bahia, 45029-094, Brazil.
Ariadne Yasmim Martins AlvesMultidisciplinary Institute in Health - Federal of Bahia University (UFBA), Vitória da Conquista, Bahia, 45029-094, Brazil.
Juliana de Souza do NascimentoDepartment of Diagnosis and Therapeutics - State University of Rio de Janeiro (UERJ), Rio de Janeiro, Brazil.
Davi Tanajura CostaMultidisciplinary Institute in Health - Federal of Bahia University (UFBA), Vitória da Conquista, Bahia, 45029-094, Brazil.
Fernanda Khouri BarretoMultidisciplinary Institute in Health - Federal of Bahia University (UFBA), Vitória da Conquista, Bahia, 45029-094, Brazil. fernanda.khouri@hotmail.com.ORCID http://orcid.org/0000-0002-0088-9036

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human T-cell lymphotropic virus type 1 (HTLV-1) is endemic in several regions worldwide and is associated with a wide spectrum of clinical manifestations with complex and still poorly understood pathogenesis. Among the reported outcomes in people living with HTLV-1, oral alterations stand out due to their potential negative impact on quality of life. Here, we reviewed the literature on HTLV-1 oral outcomes through a structured narrative review conducted in accordance with the SANRA principles. The most frequently reported oral complications include xerostomia, hyposalivation, periodontal disease, and mucosal lesions, which are commonly associated with inflammatory processes and salivary gland dysfunction. These findings underscore the importance of oral health within the multidisciplinary care of individuals living with HTLV-1, highlighting the need for preventive and therapeutic strategies that enhance overall well-being. Nevertheless, significant gaps remain in the literature, underscoring the need to expand research efforts, strengthen professional training, and increase awareness regarding oral care in this population.

Indexed as

Human T-lymphotropic virus type 1Oral healthOral ManifestationsQuality of Life

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.